Researcher at the Research Institute for Medicines (Instituto de Investigação do Medicamento), iMed.ULisboa, at the University of Lisbon. Ph.D. in Pharmacy (Faculty of Pharmacy, University of Lisbon, 2014), MSc in Applied Microbiology (Faculty of Sciences, University of Lisbon, 2010) and a Degree in Microbiology (Faculty of Medicine, University of Lisbon, 2009). Principal Investigator in 1 project starting in 2022. Published 14 articles in peer-reviewed international research journals (9 as the first author or shared first author) and 2 book sections, with 346 citations and an h-index of 10 (Scopus, Elsevier, 1st of March, 2022). Co-supervises 1 Ph.D. thesis. Supervised 1 MSc dissertation and co-supervised other 2. Participated as a jury in 5 MSc thesis committees. Received 3 awards and honors for the merit of the scientific research. Review editor in Frontiers in Microbiology and Frontiers in Immunology. Participated in 8 projects as a researcher and 1 as a Post-doctoral fellow. Is part of the team of investigators of 1 patent pending approval. The network of co-authors in scientific papers accounts for 56 collaborators. I am interested in host-pathogen interactions during M. tuberculosis and HIV infection of host immune cells. These pathogens manipulate host cells at different stages of infection inhibiting cellular processes and resisting antimicrobial mechanisms. I have been focusing my studies on finding new mechanisms and drugs that allow us to manipulate the host cellular response to infection while also targeting the pathogen itself. This dual approach to infection reduces the probability of the emergence of new drug-resistant strains and improves conventional therapy.